GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nitric oxide reductase flrd- NAD(+) reductase (B1LQ29)

Analyse AlphaFold monomer V2.0 prediction for nitric oxide reductase flrd- NAD(+)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B1LQ29
Type
protein
Length
377 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xd10960F956646DE8b64d3598984c91C2d5Af3D7b
Molecule
Nitric oxide reductase flrd-NAD(+) reductase
UniProt
B1LQ29
Pockets
1 · best druggability 0.78

Structure

1 distinct chain · 27% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANitric oxide reductase flrd-NAD(+) reductaseprotein37727% helix, 31% strandB1LQ29

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111160.780.80104empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.